Skip to Main Content

Paper Details

SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia.
Blood Adv
4
2023
3' region, AML, Ara-C, Ara-CTP, Cytarabine arabinoside, SAM and HD domain-containing deoxynucleoside triphosphate triphosphohydrolase 1, SAMHD1, SAMHD1 gene, SNPs, acute myeloid leukemia, children, patient, patients, pediatric, proliferating, proliferating cells, rs1291128, rs1291141, rs7265241, single nucleotide polymorphisms, triphosphate
Author NameAffiliation
Xueyuan CaoUniversity of Tennessee Health Science Center
Xueyuan CaoUniversity of Tennessee Health Science Center
Jeffery M KlcoSt. Jude Children's Research Hospital
Xiaotu MaSt. Jude Children's Research Hospital
Xiaotu MaSt. Jude Children's Research Hospital
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Richard AplencPerelman School of Medicine, University of Pennsylvania
Richard AplencPerelman School of Medicine, University of Pennsylvania
Edward A KolbNemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Todd A Alonzo
Todd A AlonzoUniversity of Southern California
Todd A Alonzo
Todd A AlonzoUniversity of Southern California
Stanley PoundsSt. Jude Children's Research Hospital
Stanley PoundsSt. Jude Children's Research Hospital
  • 1 - 18

Datasets

Release 1.2